1. Home
  2. BKH vs GRFS Comparison

BKH vs GRFS Comparison

Compare BKH & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Black Hills Corporation

BKH

Black Hills Corporation

HOLD

Current Price

$74.34

Market Cap

5.5B

Sector

Utilities

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.67

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKH
GRFS
Founded
1941
1940
Country
United States
Spain
Employees
N/A
23800
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.5B
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
BKH
GRFS
Price
$74.34
$8.67
Analyst Decision
Buy
Hold
Analyst Count
3
2
Target Price
$76.33
$10.15
AVG Volume (30 Days)
913.0K
608.0K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
3.79%
1.65%
EPS Growth
1.79
N/A
EPS
3.98
N/A
Revenue
$2,310,000,000.00
N/A
Revenue This Year
$5.32
$5.33
Revenue Next Year
$3.82
$6.50
P/E Ratio
$18.69
$18.67
Revenue Growth
8.57
N/A
52 Week Low
$54.92
$6.19
52 Week High
$75.68
$11.14

Technical Indicators

Market Signals
Indicator
BKH
GRFS
Relative Strength Index (RSI) 59.44 38.13
Support Level $70.32 $8.24
Resistance Level $75.41 $9.11
Average True Range (ATR) 1.45 0.28
MACD -0.00 -0.07
Stochastic Oscillator 77.29 25.50

Price Performance

Historical Comparison
BKH
GRFS

About BKH Black Hills Corporation

Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: